Reagents, the chemicals used in the processing of COVID-19 tests, are one example of this. In the early days of the pandemic, Canada faced a backlog in conducting its tests due to a shortage amid the high global demand for reagents. Now, New Brunswick-based LuminUltra is capable of producing enough reagents to handle a load of 500,000 tests per month until next year.
Anand detailed several contracts the government has signed with Canadian manufacturers, saying an agreement with Medicom calls for 80 million surgical masks per year over the next 10 years from the company's factories in Quebec, as well as 20 million N95 respirators.
Another Quebec manufacturer, Logistik Unicorp, has signed on to produce 11 million medical gowns, Anand said, while Ontario's Sterling Industries and the Canadian arm of Hewlett Packard will manufacture 15.5 million face shields.
试剂（用于处理COVID-19测试的化学药品）就是其中之一。在大流行初期，由于全球试剂需求旺盛，加拿大短缺，加拿大在进行测试方面积压。现在，基于新不伦瑞克省的LuminUltra能够生产足够的试剂，直到明年，每月要处理500,000次测试。
阿南德详细介绍了政府与加拿大制造商签订的几份合同，称与Medicom达成的协议要求在未来10年内每年从该公司在魁北克的工厂内购买8000万个外科口罩，以及2000万个N95口罩。
阿南德说，魁北克的另一家制造商Logistik Unicorp已签约生产1100万件医用礼服，而安大略省的Sterling工业公司和加拿大惠普公司将生产1550万件面罩。
